ESG: Nature’s Solutions Overshadowed By Vaccine Push

Some dietary supplement providers have seen a recent spike in sales, while major pharmaceutical firms partner with global health organizations to develop synthetic chemicals to stave off the novel coronavirus.

As the deadly COVID-19 pandemic continues to take a toll on the U.S. and world economies, a spotlight has been thrust onto preventative health measures, including social-distancing, handwashing, mask-wearing, as well as immunity strengthening and protection.

(Click on image to enlarge)

Revenue of Vitamins and Nutritional Supplement Production in U.S.

To help prevent contagion from the respiratory illness, the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have each recommended actions such as handwashing, avoiding close contact with others, and daily cleaning and disinfecting of frequently touched surfaces, however, there is little, if any mention, of advice about boosting or safeguarding immunity systems by natural dietary means.

In fact, it seems the WHO, as well as the National Institute of Allergy and Infectious Diseases (NIAID), have been focusing primarily on developing therapeutics and vaccines to combat COVID-19.

NIAID noted that its “funded scientists are exploring ways to treat and prevent human coronavirus infections by working to develop new antibodies, drugs, and vaccines. Some block the virus from entering cells, some delay the immune system response, and some block viral replication.”

NIAID added that certain of its scientists have been recently testing the antiviral drug remdesivir for the illness.  

According to NIAID, remdesivir, developed by California-based biotech company Gilead Sciences (Nasdaq: GILD), is an investigational, broad-spectrum antiviral treatment. It was previously tested in humans with Ebola virus disease and “has shown promise” in animal models for treating Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), which are caused by other coronaviruses. 

1 2 3 4
View single page >> |


The author does not hold any positions in the financial instruments referenced in the materials provided.

Disclosure: The analysis in this ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.